Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis

Name: Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis
Published: 2022
License: Public Domain

Inmunotek S.L. · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

allergy immunotherapy

house dust mite allergy, perennial allergic rhinitis, allergic rhinoconjunctivitis, allergic asthma, rhinitis/ rhinoconjunctivitis, allergy, immunotherapy, mild to moderate asthma, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis

Related documents